Davide F. Robbiani, MD, PhD
Davide F. Robbiani, MD, PhD
Institute for Research in Biomedicine, Università della Svizzera italiana
Adresă de e-mail confirmată pe irb.usi.ch - Pagina de pornire
Citat de
Citat de
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
DF Robbiani, C Gaebler, F Muecksch, JCC Lorenzi, Z Wang, A Cho, ...
Nature, 1-8, 2020
Evolution of antibody immunity to SARS-CoV-2
C Gaebler, Z Wang, JCC Lorenzi, F Muecksch, S Finkin, M Tokuyama, ...
Nature 591 (7851), 639-644, 2021
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Y Weisblum, F Schmidt, F Zhang, J DaSilva, D Poston, JCC Lorenzi, ...
Elife 9, e61312, 2020
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
CO Barnes, CA Jette, ME Abernathy, KMA Dam, SR Esswein, HB Gristick, ...
Nature, 2020
Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo
GJ Randolph, K Inaba, DF Robbiani, RM Steinman, WA Muller
Immunity 11 (6), 753-761, 1999
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies
CO Barnes, AP West Jr, KE Huey-Tubman, MAG Hoffmann, NG Sharaf, ...
Cell 182 (4), 828-842. e16, 2020
The Leukotriene C 4 Transporter MRP1 Regulates CCL19 (MIP-3β, ELC)–Dependent Mobilization of Dendritic Cells to Lymph Nodes
DF Robbiani, RA Finch, D Jäger, WA Muller, AC Sartorelli, GJ Randolph
Cell 103 (5), 757-768, 2000
MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation
Y Dorsett, KM McBride, M Jankovic, A Gazumyan, TH Thai, DF Robbiani, ...
Immunity 28 (5), 630-638, 2008
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
F Schmidt, Y Weisblum, F Muecksch, HH Hoffmann, E Michailidis, ...
Journal of Experimental Medicine 217 (11), 2020
AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations
DF Robbiani, A Bothmer, E Callen, B Reina-San-Martin, Y Dorsett, ...
Cell 135 (6), 1028-1038, 2008
Identification of early replicating fragile sites that contribute to genome instability
JH Barlow, RB Faryabi, E Callén, N Wong, A Malhowski, HT Chen, ...
Cell 152 (3), 620-632, 2013
Rif1 Prevents Resection of DNA Breaks and Promotes Immunoglobulin Class Switching
M Di Virgilio, E Callen, A Yamane, W Zhang, M Jankovic, AD Gitlin, ...
Science 339 (6120), 711-715, 2013
AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies
M Chesi, DF Robbiani, M Sebag, WJ Chng, M Affer, R Tiedemann, ...
Cancer cell 13 (2), 167-180, 2008
Enhanced SARS-CoV-2 neutralization by dimeric IgA
Z Wang, JCC Lorenzi, F Muecksch, S Finkin, C Viant, C Gaebler, ...
Science Translational Medicine, 2020
Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma
M Chesi, LA Brents, SA Ely, C Bais, DF Robbiani, EA Mesri, WM Kuehl, ...
Blood 97 (3), 729-736, 2001
Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes
IA Klein, W Resch, M Jankovic, T Oliveira, A Yamane, H Nakahashi, ...
Cell 147 (1), 95-106, 2011
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
AJ Greaney, TN Starr, CO Barnes, Y Weisblum, F Schmidt, M Caskey, ...
Nature Communications 12 (1), 1-14, 2021
Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico
DF Robbiani, L Bozzacco, JR Keeffe, R Khouri, PC Olsen, A Gazumyan, ...
Cell 169 (4), 597-609. e11, 2017
53BP1 regulates DNA resection and the choice between classical and alternative end joining during class switch recombination
A Bothmer, DF Robbiani, N Feldhahn, A Gazumyan, A Nussenzweig, ...
Journal of Experimental Medicine 207 (4), 855-865, 2010
Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis
M Uguccioni, P Gionchetti, DF Robbiani, F Rizzello, S Peruzzo, ...
The American journal of pathology 155 (2), 331-336, 1999
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20